CoChat

Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests

Open access
Nathavitharana, Ruvandhi R, Yoon, Christina, Macpherson, Peter, Dowdy, David W, Cattamanchi, Adithya, Somoskovi, Akos, Broger, Tobias, Ottenhoff, Tom H M, Arinaminpathy, Nimalan, Lonnroth, Knut, Reither, Klaus, Cobelens, Frank, Gilpin, Christopher, Denkinger, Claudia M, Schumacher, Samuel G · 2019 · The Journal of Infectious Diseases
Cited by 45

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Approximately 3.6 million cases of active tuberculosis (TB) go potentially undiagnosed annually, partly due to limited access to confirmatory diagnostic tests, such as molecular assays or mycobacterial culture, in community and primary healthcare settings. This article provides guidance for TB triage test evaluations. A TB triage test is designed for use in people with TB symptoms and/or significant risk factors for TB. Triage tests are simple and low-cost tests aiming to improve ease of access and implementation (compared with confirmatory tests) and decrease the proportion of patients requiring more expensive confirmatory testing. Evaluation of triage tests should occur in settings of intended use, such as community and primary healthcare centers. Important considerations for triage test evaluation include study design, population, sample type, test throughput, use of thresholds, reference standard (ideally culture), and specimen flow. The impact of a triage test will depend heavily on issues beyond accuracy, primarily centered on implementation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jiz243

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 43

  1. World Health Organization, 2018, Global Tuberculosis Control. WHO Report 2018
  2. Cheng, 2013, Effect of diagnostic and treatment delay on the risk of tuberculosis transmission in Shenzhen, China: an observational cohort study, 1993-2010, PLoS One, 8, e67516, 10.1371/journal.pone.0067516 · DOI
  3. Cohen, 2010, The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study, PLoS Med, 7, e1000296, 10.1371/journal.pmed.1000296 · DOI
  4. Bates, 2015, Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study, Lancet Infect Dis, 15, 544, 10.1016/S1473-3099(15)70058-7 · DOI
  5. Sreeramareddy, 2009, Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature, BMC Infect Dis, 9, 91, 10.1186/1471-2334-9-91 · DOI · Paper page
  6. Getnet, 2017, Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: systematic review and meta-analysis, BMC Pulm Med, 17, 202, 10.1186/s12890-017-0551-y · DOI · Paper page
  7. Huddart, 2016, Location, location, location: tuberculosis services in highest burden countries, Lancet Glob Health, 4, e907, 10.1016/S2214-109X(16)30248-0 · doi:10.1016/s2214-109x(16)30248-0
  8. World Health Organization, 2011, Policy Statement: Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF
  9. World Health Organization, 2016, Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis Of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update
  10. World Health Organization, 2018, WHO Meeting Report of a Technical Expert Consultation: Non-inferiority analysis of Xpert MTB/RIF ultra compared to Xpert MTB/RIF
  11. Albert, 2016, Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?, Eur Respir J, 48, 516, 10.1183/13993003.00543-2016 · DOI · Paper page
  12. Theron, 2014, Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial, Lancet, 383, 424, 10.1016/S0140-6736(13)62073-5 · DOI · Paper page
  13. Médecins Sans Frontières, 2017, Out of Step: TB policies in 29 countries
  14. Nathavitharana, 2017, Accuracy of line probe assays for the diagnosis of pulmonary TB and detection of resistance to rifampicin and isoniazid: a systematic review and meta-analysis, Eur Respir J, 49, 1601075, 10.1183/13993003.01075-2016 · DOI · Paper page
  15. Shete, 2019, Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis, BMC Infect Dis, 19, 268, 10.1186/s12879-019-3881-y · DOI
  16. FIND diagnostic pipeline
  17. Bossuyt, 2006, Comparative accuracy: assessing new tests against existing diagnostic pathways, BMJ, 332, 1089, 10.1136/bmj.332.7549.1089 · DOI · Paper page
  18. World Health Organization, 2014, High-priority target product profiles for new tuberculosis diagnostics: Report of a consensus meeting
  19. Kik, 2014, Tuberculosis diagnostics: which target product profiles should be prioritised?, Eur Respir J, 44, 537, 10.1183/09031936.00027714 · DOI
  20. World Health Organization, 2013, Systematic screening for active tuberculosis: Principles and recommendations
  21. Van’t Hoog, 2014, Choosing algorithms for TB screening: a modelling study to compare yield, predictive value and diagnostic burden, BMC Infect Dis, 14, 532, 10.1186/1471-2334-14-532 · DOI · Paper page
  22. Chihota, 2015, Missed opportunities for TB investigation in primary care clinics in South Africa: experience from the XTEND trial, PLoS One, 10, e0138149, 10.1371/journal.pone.0138149 · DOI
  23. Claassens, 2013, Tuberculosis cases missed in primary health care facilities: should we redefine case finding?, Int J Tuberc Lung Dis, 17, 608, 10.5588/ijtld.12.0506 · DOI · Paper page
  24. Kweza, 2018, Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa, Int J Tuberc Lung Dis, 22, 264, 10.5588/ijtld.17.0491 · DOI
  25. Roy, 2016, Implementation and operational research: use of symptom screening and sputum microscopy testing for active tuberculosis case detection among HIV-infected patients in real-world clinical practice in Uganda, J Acquir Immune Defic Syndr, 72, e86, 10.1097/QAI.0000000000001067 · doi:10.1097/qai.0000000000001067
  26. MacLean, 2019, Author Correction: a systematic review of biomarkers to detect active tuberculosis, Nat Microbiol, 4, 899, 10.1038/s41564-019-0452-3 · doi:10.1038/s41564-019-0452-3
  27. Pande, 2016, Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review, Int J Tuberc Lung Dis, 20, 1226, 10.5588/ijtld.15.0926 · DOI · Paper page
  28. Barrera, 2015, F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy, Int J Tuberc Lung Dis, 19, 381, 10.5588/ijtld.14.0680 · doi:10.5588/ijtld.14.0680
  29. Nathavitharana, 2017, FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-up, Int J Tuberc Lung Dis, 21, 1020, 10.5588/ijtld.16.0794 · DOI
  30. Yoon, 2019, Screening for tuberculosis: time to move beyond symptoms, Lancet Respir Med, 7, 202, 10.1016/S2213-2600(19)30039-6 · DOI
  31. Ahmad Khan, 2017, Computer-aided reading of tuberculosis chest radiography: moving the research agenda forward to inform policy, Eur Respir J, 50, 10.1183/13993003.00953-2017 · DOI · Paper page
  32. Yoon, 2017, Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis, Int J Tuberc Lung Dis, 21, 1013, 10.5588/ijtld.17.0078 · DOI
  33. Yoon, 2017, Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study, Lancet Infect Dis, 17, 1285, 10.1016/S1473-3099(17)30488-7 · DOI
  34. Chegou, 2016, Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB, Thorax, 71, 785, 10.1136/thoraxjnl-2015-207999 · DOI
  35. De Groote, 2017, Discovery and validation of a six-marker serum protein signature for the diagnosis of active pulmonary tuberculosis, J Clin Microbiol, 55, 3057, 10.1128/JCM.00467-17 · DOI
  36. Phillips, 2012, Point-of-care breath test for biomarkers of active pulmonary tuberculosis, Tuberculosis (Edinb), 92, 314, 10.1016/j.tube.2012.04.002 · DOI · Paper page
  37. Nliwasa, 2018, High HIV and active tuberculosis prevalence and increased mortality risk in adults with symptoms of TB: a systematic review and meta-analyses, J Int AIDS Soc, 21, e25162, 10.1002/jia2.25162 · DOI
  38. Datiko, 2019, Sub-national prevalence survey of tuberculosis in rural communities of Ethiopia, BMC Public Health, 19, 295, 10.1186/s12889-019-6620-9 · doi:10.1186/s12889-019-6620-9
  39. Leeflang, 2008, Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions, Clin Chem, 54, 729, 10.1373/clinchem.2007.096032 · DOI · Paper page
  40. World Health Organization, 2007, Policy statement: liquid media for culture and DST
  41. Esmail, 2016, Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography, Nat Med, 22, 1090, 10.1038/nm.4161 · DOI · Paper page
  42. Schumacher, 2016, Diagnostic test accuracy in childhood pulmonary tuberculosis: a Bayesian latent class analysis, Am J Epidemiol, 184, 690, 10.1093/aje/kww094 · DOI · Paper page
  43. Yoon, 2019, Yield and efficiency of novel intensified tuberculosis case-finding algorithms for people living with HIV, Am J Respir Crit Care Med, 199, 643, 10.1164/rccm.201803-0490OC · DOI

Cited by

See all 45

Metadata

Authors
Nathavitharana, R. R., Yoon, C., Macpherson, P., Dowdy, D. W., Cattamanchi, A., Somoskovi, A., Broger, T., Ottenhoff, T. H. M., Arinaminpathy, N., Lonnroth, K., Reither, K., Cobelens, F., Gilpin, C., Denkinger, C. M., & Schumacher, S. G.
Venue
The Journal of Infectious Diseases
Published
2019-10-08
Volume
220
Issue
Supplement_3
Pages
S116-S125
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2979533273
Cited by
45
References
5
FWCI
4.80
Type
journal article
Language
en
Open access
bronze
Funders
  • National Institute of Allergy and Infectious Diseases (K23 AI13264801A1)
  • American Society of Tropical Medicine and Hygiene
  • Harvard Center for AIDS Research Scholar Award (2P30AI060354-11)
  • National Institutes of Health (K23 AI114363)
  • Wellcome Trust (206575)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests. https://app.cochat.ai/papers/10.1093/infdis/jiz243
The paper
Nathavitharana, R. R., Yoon, C., Macpherson, P., Dowdy, D. W., Cattamanchi, A., Somoskovi, A., Broger, T., Ottenhoff, T. H. M., Arinaminpathy, N., Lonnroth, K., Reither, K., Cobelens, F., Gilpin, C., Denkinger, C. M., & Schumacher, S. G. (2019). Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiz243

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.